Amneal Pharmaceuticals (AMRX) Announces FDA Filing Acceptance of Abbreviated NDA for Naloxone Hydrochloride Nasal Spray, USP, 4mg

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. SPY
2. META
3. USO
4. MSFT
5. MU
6. COST
7. IONS
8. AVAV
9. SKHY
10. CG

Go back to Amneal Pharmaceuticals (AMRX) Announces FDA Filing Acceptance of Abbreviated NDA for Naloxone Hydrochloride Nasal Spray, USP, 4mg
AmerElite Solutions, Inc. New (NASDAQ: AMRX) Delayed: 17.02 +0.06 (0.35%)
Previous Close $16.96    52 Week High $0.19 
Open $17.02    52 Week Low $0.07 
Day High $17.19    P/E N/A 
Day Low $16.76    EPS $-0.01 
Volume 1,553,761